SeaCrest Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $203K | Sell |
525
-742
| -59% | -$275K | 0.02% | 525 |
|
|
2026
Q1 | $371K | Sell |
1,267
-71
| -5% | -$23.3K | 0.04% | 417 |
|
|
2025
Q4 | $491K | Sell |
1,338
-55
| -4% | -$18.6K | 0.05% | 330 |
|
|
2025
Q3 | $505K | Buy |
1,393
+125
| +10% | +$38.9K | 0.05% | 310 |
|
|
2025
Q2 | $493K | Sell |
1,268
-1,206
| -49% | -$485K | 0.05% | 316 |
|
|
2025
Q1 | $1.08M | Buy |
2,474
+378
| +18% | +$152K | 0.12% | 164 |
|
|
2024
Q4 | $773K | Sell |
2,096
-240
| -10% | -$100K | 0.08% | 230 |
|
|
2024
Q3 | $1.21M | Buy |
2,336
+41
| +2% | +$21.9K | 0.13% | 146 |
|
|
2024
Q2 | $1.24M | Buy |
2,295
+32
| +1% | +$16.9K | 0.14% | 138 |
|
|
2024
Q1 | $1.17M | Sell |
2,263
-47
| -2% | -$23.4K | 0.14% | 154 |
|
|
2023
Q4 | $1.11M | Buy |
2,310
+95
| +4% | +$43.9K | 0.14% | 152 |
|
|
2023
Q3 | $964K | Buy |
2,215
+86
| +4% | +$39K | 0.13% | 171 |
|
|
2023
Q2 | $946K | Sell |
2,129
-35
| -2% | -$16.1K | 0.12% | 178 |
|
|
2023
Q1 | $995K | Sell |
2,164
-13
| -0.6% | -$6.19K | 0.13% | 166 |
|
|
2022
Q4 | $1.12M | Sell |
2,177
-53
| -2% | -$26.9K | 0.16% | 146 |
|
|
2022
Q3 | $1.01M | Buy |
2,230
+42
| +2% | +$20.1K | 0.15% | 141 |
|
|
2022
Q2 | $1.06M | Buy |
2,188
+53
| +2% | +$26.2K | 0.13% | 164 |
|
|
2022
Q1 | $1.05M | Buy |
2,135
+173
| +9% | +$79.1K | 0.12% | 184 |
|
|
2021
Q4 | $909K | Sell |
1,962
-21
| -1% | -$8.84K | 0.1% | 209 |
|
|
2021
Q3 | $739K | Sell |
1,983
-61
| -3% | -$23.2K | 0.09% | 236 |
|
|
2021
Q2 | $780K | Buy |
2,044
+126
| +7% | +$48.2K | 0.09% | 233 |
|
|
2021
Q1 | $688K | Buy |
1,918
+46
| +2% | +$14.8K | 0.09% | 241 |
|
|
2020
Q4 | $601K | Buy |
1,872
+156
| +9% | +$47.9K | 0.08% | 252 |
|
|
2020
Q3 | $461K | Sell |
1,716
-32
| -2% | -$8.61K | 0.07% | 268 |
|
|
2020
Q2 | $460K | Buy |
1,748
+11
| +0.6% | +$2.94K | 0.08% | 264 |
|
|
2020
Q1 | $394K | Sell |
1,737
-163
| -9% | -$44.4K | 0.08% | 260 |
|
|
2019
Q4 | $574K | Buy |
1,900
+5
| +0.3% | +$1.38K | 0.1% | 243 |
|
|
2019
Q3 | $455K | Sell |
1,895
-16
| -0.8% | -$4.38K | 0.09% | 279 |
|
|
2019
Q2 | $539K | Buy |
1,911
+54
| +3% | +$14.8K | 0.11% | 225 |
|
|
2019
Q1 | $533K | Buy |
1,857
+7
| +0.4% | +$2.02K | 0.09% | 221 |
|
|
2018
Q4 | $486K | Sell |
1,850
-156
| -8% | -$42.9K | 0.1% | 207 |
|
|
2018
Q3 | $550K | Buy |
2,006
+56
| +3% | +$14.5K | 0.09% | 237 |
|
|
2018
Q2 | $464K | Buy |
1,950
+115
| +6% | +$26.6K | 0.08% | 263 |
|
|
2018
Q1 | $403K | Sell |
1,835
-45
| -2% | -$10.6K | 0.07% | 293 |
|
|
2017
Q4 | $423K | Buy |
+1,880
| New | +$400K | 0.08% | 281 |
|
Other funds holding ELV
SeaCrest Wealth Management's ELV Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its Elevance Health (ELV) stake by 59% in Q2 2026, selling an estimated $275K and leaving 525 shares worth $203K. The position accounts for 0.02% of the portfolio, ranked #525.
SeaCrest Wealth Management first reported a position in ELV in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.24M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- SeaCrest Wealth Management held 525 shares of Elevance Health worth $203K as of Q2 2026.
- SeaCrest Wealth Management sold 742 Elevance Health shares in Q2 2026, an estimated $275K.
- Elevance Health made up 0.02% of SeaCrest Wealth Management's portfolio in Q2 2026, its #525 holding.
- SeaCrest Wealth Management first reported a position in Elevance Health in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's Elevance Health position peaked at $1.24M in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.